LORAPLUS TAB
Each uncoated tablet contains: Loratadine USP 10 mg Excipients q.s.
| Composition | Each uncoated tablet contains: Loratadine USP 10 mg Excipients q.s. |
| Packing | BLISTER AMBER PVC - 10*10 |
| MRP | ₹73 |
Product Overview
LORAPLUS TAB is a long-acting, non-sedating second-generation antihistamine formulated to treat seasonal and perennial allergic symptoms. It provides continuous 24-hour relief from respiratory and dermatological allergy triggers without causing daytime drowsiness.
Indications
This antihistamine tablet is clinically indicated for:
- Allergic Rhinitis: Provides rapid relief from sneezing, rhinorrhea, nasal pruritus, and ocular burning.
- Chronic Idiopathic Urticaria: Minimizes the presentation of itchy hives, skin wheals, and localized swelling.
- Allergic Conjunctivitis: Reduces tear secretion, redness, and itching of the eyes.
Dosage & Administration
Adults and children aged 12 years and older: One 10 mg tablet orally once daily, with or without food. For patients with severe hepatic impairment, an initial dose of 10 mg every alternate day is advised.
Adverse Effects
Extremely well tolerated; adverse events occur at rates similar to a placebo. Mild reactions may include:
- Transient headache
- Fatigue or mild somnolence (rare at 10 mg dose)
- Dry mouth or gastrointestinal upset
View Complete Medical Information
Contraindications
Contraindicated in patients who demonstrate documented hypersensitivity or idiosyncratic reactions to loratadine, desloratadine, or any inert excipients in the tablet.
Warnings & Precautions
Patients with severe hepatic impairment should receive a reduced initial dose due to decreased clearance of the drug. Antihistamines should be discontinued at least 48 hours before undergoing diagnostic skin allergy testing to prevent false-negative results.
Drug Interactions
Concomitant administration with CYP3A4 or CYP2D6 inhibitors such as ketoconazole, erythromycin, or cimetidine may increase plasma concentrations of loratadine slightly, though this rarely translates into clinical adverse symptoms.
Storage Instructions
Store below 30°C in a dry environment. Keep the tablets inside their original blister packaging until use to protect from ambient light.
Product image not available
Request This Product
- WHO-GMP Certified Formulations
- Monopoly Rights Available
- Get bulk pricing & MOQ
+91 9689237122 · replies within hours
Related Products
More products in the COUGH PREPARATION therapeutic category
CICITRI TAB
Each Film Coated Tablet Contains: Cetirizine Dihydrochloride IP 10mg Excipients q.s
BLISTER CLEAR PVC - 10*20
CICOF T SYP 100 ML
Each 5 ml Contains : Terbutaline Sulphate IP 1.25 mg Ambroxol Hydrochloride IP 15 mg Guaiphenesin IP 50 mg Menthol IP 1.5 mg In a Flavoured Syrupy Base q.s.
PET AMBER BOTTLE WITH MEASURING CAP - 100 ML
CICOF DS
Each 5 ml contains Phenylephrine 5mg+ Chlorpheniramine Maleate 2mg+ Dextromethorphan Hydrobromide 15mg
PET AMBER BOTTLE - 100 ML
Interested in this product?
Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.